Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ALNY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Alnylam Pharmaceuticals Inc's percent of analysts bearish on the stock is less than nearly 100% of all US stocks.
- ALNY has a greater number of analysts covering the stock than 98.78% of Pharmaceutical Products stocks.
- Alnylam Pharmaceuticals Inc's average analyst price target is greater than 95.63% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of ALNY is higher than 90.9% of stocks in the large market cap category.
- The variance in analysts' estimates of ALNY is lower than 9.28% of all US stocks.
- ALNY has a higher percentage of analysts bullish on the stock than 28.24% of Pharmaceutical Products stocks.
- ALNY has a less change in bullishness amongst analysts than nearly 100% of all US stocks.
Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!